A phase II trial of alpha-interferon and 5-fluorouracil in patients with advanced carcinoid and islet cell tumors
- 1 August 1994
- Vol. 74 (3) , 958-961
- https://doi.org/10.1002/1097-0142(19940801)74:3<958::aid-cncr2820740326>3.0.co;2-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumorsCancer, 1993
- Long-Term Management of the Carcinoid Syndrome Treatment with octreotide alone and in combination with alpha-interferonActa Oncologica, 1993
- Treatment of Carcinoid Syndrome with Recombinant Interferon Alpha-2aActa Oncologica, 1993
- Combined Alpha- and Gamma-Interferon Therapy for Malignant Midgut Carcinoid Tumors a phase I-II trialActa Oncologica, 1993
- Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell CarcinomaNew England Journal of Medicine, 1992
- Treatment of malignant carcinoid tumors: a randomized controlled study of streptozocin plus 5-FU and human leukocyte interferonEuropean Journal of Cancer and Clinical Oncology, 1989
- Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor.Journal of Clinical Oncology, 1984
- Treatment of the carcinoid tumor and the malignant carcinoid syndrome.Journal of Clinical Oncology, 1983
- Streptozocin Alone Compared with Streptozocin plus Fluorouracil in the Treatment of Advanced Islet-Cell CarcinomaNew England Journal of Medicine, 1980
- Pancreatic Islet Cell CarcinomaAnnals of Internal Medicine, 1973